跳至主要内容
临床试验/NCT00561236
NCT00561236已完成不适用

Low Dose (1mcg ) ACTH Stimulation Test for Assessment of the Hypothalamo- Pituitary- Adrenal Axis in Patients Treated With Intravitreal Injection of Triamcinolone Acetonide

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1

研究概览

简要总结

The use of intravitreal corticosteroids in the management ocular inflammatory diseases has recently gained widespread acceptance. The purpose of this study is to determine if the use of intravitreal triamcinolone is associated with suppression of endogenous cortisol production, as generally admitted for patients treated with oral or parenteral corticosteroid therapy.

详细描述

The normalcy of hypothalamic- pituitary- adrenal axis (HPA axis) of enrolled subjects will will be assessed before intravitreal injection of 4mg of triamcinolone and again after one day, one week and two weeks. Patients with abnormal HPA axis will be re-tested after four weeks and later until the HPA axis function return to normal. The HPA axis will be assessed with low dose (1mcg) intravenous corticotropin(ACTH) stimulation test, in which cortisol levels will be sampled before , 30 minutes and 60 minutes after 1mcg ACTH IV injection.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients receiving intravitreous injection of triamcinolone 4mg

排除标准

  • patients receiving steroids in any form, except by intravitreous administration

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

avraham ishay

Dr

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验

Does Intravitreal Injection of Triamcinolone... | 临床试验